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Abstract
Background: A previous randomized controlled trial (RCT) of the Swedish National Tobacco Quitline detected no
significant differences in smoking cessation outcomes between proactive and reactive services at 12-month follow-up.
However, the response rate was only 59 % and non-responders were over-represented in the proactive service. We
performed a drop-out analysis to assess the smoking status of initial responders and non-responders.
Methods: At 29–48 months after the first call, a postal questionnaire with six questions was sent to 150 random
clients from the RCT database, with equal numbers from the proactive and reactive services as well as responders
and non-responders at 12-month follow-up. Clients who did not return the questionnaire were contacted by
telephone. The outcome measures were point prevalence (PP) and 6-month continuous abstinence (CA), and
their associations with response status at 12 months were assessed by logistic regression.
Results: The response rate was 74 % (111/150). Abstinence was significantly higher among initial responders than
non-responders (PP 54 % vs. 32 %, p = .023 and CA 49 % vs. 21 %, p = .003). The odds ratios for initial responders vs.
initial non-responders were, for PP = 2.5 (95 % CI 1.1–5.6, p = .024), and for CA = 3.7 (95 % CI 1.5–8.9, p = .004), after
adjusting for proactive/reactive service.
Conclusions: Non-responders to a 12-month follow-up smoking cessation questionnaire in a quitline setting were
more likely to be smokers 1.5–3 years later. We propose a conservative correction factor of 0.8 for self-reported
abstinence in telephone-based cessation studies if the response rate is approximately 55–65 %.
Keywords: Effectiveness, Intention-to-treat, Non-response, Per protocol, Proactive, Reactive, Responder-only
analysis, Smoking, Telephone, Questionnaire
Background
Tobacco control remains a critical public health chal-
lenge, and thus encouraging smoking cessation is crucial
for reducing tobacco-related mortality and morbidity in
future years [1]. In Sweden, the prevalence of adult daily
smoking has steadily declined since the 1980s to 10 % in
2014 [2]. However, in Sweden, which has a population of
nearly 10 million, 1.6 million people still use tobacco
(cigarettes and/or snus [moist snuff]) every day and it is
estimated that 12,000 people die from smoking-related
diseases each year (33 per day) [3].
Telephone-based counselling (via quitlines) is an
evidence-based option for tobacco cessation support,
which is both effective and cost-effective [4, 5]. Quitlines
usually offer both a reactive service where only incoming
calls are attended and a proactive service that offers call-
backs. According to meta-analyses, the odds of quitting
are 40 % higher for smokers who call quitlines and who
receive multiple proactive counselling compared with
controls who receive brief counselling and/or self-help
materials by mail [4, 5].
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Postal questionnaires are commonly used to measure
the effectiveness of quitlines. In Nordic countries, the re-
sponse rates to questionnaires have generally decreased
during recent decades, which might affect the trust-
worthiness of studies employed to evaluate effectiveness
[6]. The North American Quitline Consortium (NAQC),
an organization that provides leadership in promoting
evidence-based quitline services for the United States
and Canada, recommend 50 % as a minimum survey re-
sponse rate for studies reporting quit rates [7]. In 2013,
six out of 36 quitlines in the USA and Canada achieved
the recommended 50 % response rate, with rates be-
tween 13 and 59 % and an average of 41 % [8].
In Sweden, ever since it was found that smokers are
over-represented among non-responders to population-
based questionnaire assessments of living conditions [9],
the usual practice has been to treat non-responders as
smokers in intention-to treat (ITT) analyses. This con-
servative approach will not overestimate the treatment
effect but it may yield underestimates because not all
non-responders are likely to be smokers. Indeed, a previ-
ous drop-out study of the Swedish National Tobacco
Quitline (SNTQ) concluded that treating non-
responders at 12-month follow-up as smokers might sig-
nificantly underestimate the true effect of cessation
treatment [10].
The SNTQ is a free service that operates nationwide,
which is partly financed by the Stockholm County
Council Health Service but the Swedish Government is
the main financing body. The SNTQ started in 1998
with a reactive service. In 1999, a proactive service was
introduced and clients could choose between a reactive
or proactive service. Previous studies have reported a ca
30 % point prevalence abstinence (responders only) at
12-month follow-up, with a cost per life-year saved of
about 400 USD [11, 12], and the proactive service was
considered to be marginally more effective than the re-
active service for women but not for men [11]. However,
these results are based on non-randomized studies
where the clients could choose the service that they
wanted.
To facilitate a better comparison of the effectiveness of
the higher-intensity proactive service and that of the
lower-intensity reactive service, a randomized controlled
trial was performed during 2009–2010, in the sequel
called the RCT-study [13]. No statistically significant dif-
ferences in smoking cessation outcomes were detected
at the 12-month follow-up between the proactive and re-
active services, in terms of point prevalence or continu-
ous abstinence, or ITT or responder-only analyses.
However, there were some differences in the baseline
characteristics of the responders and non-responders to
the 12-month follow-up [13]. In particular, it was inter-
esting that although there were no differences between
the proactive and reactive services in terms of data col-
lection and recruitment, the clients who received the
proactive service were significantly less likely to respond
to the 12-month follow-up questionnaire [13].
Overall, the proportion of responders to the 12-month
follow-up postal questionnaires sent by the SNTQ has
decreased over time from about 70 % in 1999 to 60 % at
the time of the present study [11, 13, 14]. This decline in
the response rate suggests the need for a new non-
responder analysis to assess the possible effects on the
proportion of clients who are still smokers among the
non-responders. In addition, as non-responders were
over-represented in the proactive service [13], a com-
parison between the different services is required.
The present study was the second non-responder/
drop-out analysis to be conducted at the SNTQ. The
main hypothesis tested in this study is that non-
responders to the 12-month follow-up are more likely to
be smokers at the time of the non-response analysis
compared with responders to the 12-month follow-up
questionnaire. We also assessed whether the two differ-
ent treatment services (proactive and reactive) yielded




The SNTQ and the counselling process have been
described previously [11, 13], but we provide a brief
description of the standard SNTQ process.
All calls to the SNTQ are registered in a computerized
database. When a tobacco user calls to discuss his/her
personal tobacco behaviour, the counsellor asks whether
the client would like to sign up for cessation support. If
the client gives verbal consent, their preference for call-
back (proactive service) or no call-back (reactive service)
is recorded, and a registration form, which includes the
baseline questionnaire, is mailed to them. The return of
the baseline questionnaire is regarded as informed con-
sent and the client is included in a study base to assess
effectiveness. Twelve months after the first call, a
follow-up questionnaire is sent by mail to the client.
Non-responders to the baseline or follow-up question-
naire receive up to two reminders, one by mail, and
one by telephone.
The RCT study
The initial RCT study was performed as part of the
normal operation at the SNTQ, where the only differ-
ence was that callers were not offered a choice of
callbacks or no callbacks. Instead, only those who
called on even dates were offered callbacks, i.e., the
proactive service, and those who called on odd dates
were informed that they could call back themselves
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whenever they liked, i.e., the reactive service. The
study base comprised the 586 clients who returned
the baseline questionnaire during the recruitment
period: 303 from the proactive service group and 283
from the reactive service group (Fig. 1) [13].
The drop-out study
The drop-out study was performed between 2 years
5 months and 4 years (29–48 months) after the client’s
first call, and thus it may be defined as both a drop-out
study and a long-term follow-up of the SNTQ results. A
questionnaire was compiled with six questions, all of
which had been validated and used previously in the
baseline and 12-month follow-up questionnaires in the
initial RCT study [13]. The questions included smoking
habits, use of snus and pharmaceuticals (nicotine re-
placement therapy (NRT), Champix® and Zyban®), and
intention to quit (if still smoking). The questionnaire
was pre-tested by six clients.
A random sample of 60 % of the clients in the RCT
database was drawn from each of the four categories;
proactive 12-month responders, proactive 12-month
non-responders, reactive 12-month responders, and re-
active 12-month non-responders. The national popula-
tion register was then checked for deaths and
emigration details. Since the clients were drawn ran-
domly their order is random and thus we drew the cli-
ents consecutively from each of the four categories. The
target was to get around 40 from each category. This
was based on previous power calculations where we as-
sumed at least 20 % difference between the groups.
The questionnaires were posted to the clients with a
cover letter and the clients were asked to return the an-
swered questionnaire in an enclosed stamped envelope.
Those who did not return the questionnaire were con-
tacted by telephone and they could choose whether to
return the questionnaire or to answer the questions dur-
ing a structured telephone interview. The six clients
from the pre-test (two in the proactive group and four
in the reactive group, where all six were initial re-
sponders) were also included because no changes to the
questionnaire were required after the pre-test. The flow
chart of the study is presented in Fig. 1.
Abstinence questions and outcomes
Abstinence was assessed by two questions: 1) “Have you
smoked (one or more deep drags) during the past
7 days?” with response alternatives of “no, not at all”,
“yes, but not daily”, and “yes daily”; and 2) “When did
you take your last puff?” with response alternatives of
“0–7 days ago”, “more than 7 days but less than 6 months
ago”, “6–12 months ago”, and “more than 12 months
ago”. The outcome measures were point prevalence ab-
stinence (not a puff in the past 7 days) and 6-month
continuous abstinence (not a puff in the past 6 months)
at the 12-month follow-up.
The study was approved by the Ethical Committee at
the Karolinska Institutet (Dnr 00-367).
Data analysis
SPSS (version 22) was used to conduct all of the statis-
tical analyses and significance differences were accepted
at p < .05 (two-sided). In the comparisons of responders
and non-responders, the Mann–Whitney U-test was
used for age and the Chi-Square test was used for cat-
egorical variables, although Fisher’s exact test was ap-
plied for the use of snus. The association between
outcome and response status at 12 months after adjust-
ing for treatment was assessed by logistic regression.
McNemar’s test was used to compare the outcomes
(point prevalence and 6-month continuous abstinence)
in those who responded to both the 12-month follow-up
in the RCT study and to the drop-out study.
Results
The response rate was 74 % (111/150). Sixty-two clients
returned the questionnaires without reminders and 49
responded to the questionnaire after a telephone re-
minder. Significantly more initial responders than initial
non-responders in the proactive service replied to the
drop-out study (87 vs. 63 %, p = .015). The difference
was similar for the reactive service but it did not reach
significance (80 vs. 63 %, p = .087). The response pattern
in the drop-out study is presented in Table 1.
Almost half (45 %) of those who responded to the
drop-out study were smoke-free 29–48 months after
their first call. Abstinence was significantly higher
among responders than among non-responders to the
12-month follow-up in the original RCT study. Point
prevalence was 54 % among initial responders and
32 % among initial non-responders (p = .023), and 6-month
continuous abstinence was 49 % among initial responders
and 21 % among initial non-responders (p = .003). There
were no differences in pharmaceutical or snus use between
the groups. Intention to quit among those still smoking was
equal in both groups (Table 2).
According to the regression analysis, responders to the
initial 12-month follow-up were more than twice as
likely to be point prevalence abstinent compared with
non-responders (odds ratio (OR) 2.5, 95 % confidence
interval (CI) 1.1–5.6, p = .024) when adjusted for pro-
active/reactive service. The adjusted odds ratio was even
higher for 6-month continuous abstinence (OR 3.7, 95 %
CI 1.5–8.9, p = .004) (Table 3).
Fully 70 % of those who were smoke-free at the initial 12-
month follow-up were still smoke-free after 29–48 months.
In addition, approximately one third of those who were
smoking at 12-month follow-up reported to be smoke-free
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Fig. 1 Flowchart illustrating the process followed in the RCT and the drop-out study. Clients were included from February 2009 to September
2010. The drop-out study was performed in February to March 2013
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in the present study (Table 4). The pattern was almost the
same for the proactive and reactive services. The abstinence
at the 12-month follow-up in the original RCT study and a
comparison of the baseline characteristics among re-
sponders and non-responders to the 12-month follow-up is
previously reported [13].
The observed power in the present study was 78 % for
point prevalence abstinence and 96 % for 6-month con-
tinuous abstinence (α = 5 %) (Table 2).
Discussion
A clear response bias was detected in the present drop-
out study, where the initial responders were significantly
more likely to be smoke-free than the initial non-
responders, a difference of approximately 20 %. How-
ever, almost one third of the initial non-responders who
participated in the present study reported to be smoke-
free at the time of the drop-out assessment (Table 2).
A responder at the 12-month follow-up was 2.5
(in terms of point prevalence) and 3.7 (in terms of 6-month
continuous abstinence) times more likely to be abstinent
than a non-responder in the drop-out study, after adjusting
for proactive/reactive service (Table 3).
The stability of the long-term abstinence rate was not-
able in this long-term follow-up. Among responders at
the 12-month follow-up in the original RCT study, 47 %
Table 1 Response patterns in the drop-out study














Total number of replies to the drop-out study 84 (67/80) 63 (44/70) .004 87 (34/39) 63 (22/35) .015 80 (33/41) 63 (22/35) .087
- replies without telephone reminder 64 (43/67) 43 (19/44) .029 59 (20/34) 45 (10/22) .327 70 (23/33) 41 (9/22) .034
- replies after telephone reminder 36 (24/67) 57 (25/44) 41 (14/34) 55 (12/22) 30 (10/33) 59 (13/22)
Proportion of those who got a telephone
reminder who replied
69 (24/35) 53 (25/47) .160 74 (14/19) 52 (12/23) .153 63 (10/16) 54 (13/24) .601
aResp: responders (both baseline and 12 months)
bNon-resp: non-responders (baseline but not 12 months)
cDifferences between responders and non-responders were tested with the chi-square test
Table 2 Abstinence and other pertinent results obtained from the drop-out study
% (n/N) Total Responders (both baseline
and 12 months)
Non-responders (baseline
but not 12 months)
p-value*
Point prevalence 45 (50/111) 54 (36/67) 32 (14/44) .023
- in proactive service 41 (23/56) 50 (17/34) 27 (6/22) .091
- in reactive service 49 (27/55) 58 (19/33) 36 (8/22) .123
6-month continuous abstinence 38 (42/110) 49 (33/67) 21 (9/43) .003
- in proactive service 34 (19/56) 44 (15/34) 18 (4/22) .045
- in reactive service 43 (23/54) 55 (18/33) 24 (5/21) .026
Women 75 (83/111) 72 (48/67) 79 (35/44) .348
Age (median; q1-q3) 50; 38–58 51; 41–59 45; 34–55 .044
Pharmaceuticala use in the past 7 days 20 (22/110) 21 (14/67) 19 (8/43) .769
Pharmaceuticala use since first call to SNTQ:
- no 41 (45/109) 42 (28/66) 39 (17/43) .925
- yes, < 5 weeks 19 (21/109) 18 (12/66) 21 (9/43)
- yes, ≥ 5 weeks 39 (43/109) 39 (26/66) 39 (17/43)
Snus use in the past 7 days 11 (12/109) 12 (8/66) 9 (4/43) .761
Intention to quit (among still smokers):
- action + preparation 49 (30/61) 53 (17/32) 45 (13/29) .517
- contempl. + precont b 51 (31/61) 47 (15/32) 55 (16/29)
N = 150, response 111 (74 %). First call February 2 2009 to September 23 2010. Follow-up February to March 2013 (⇒2 years 5 months to 4 years)
*Differences between responders and non-responders were tested with the chi-square test for all variables except age which was tested with the Mann–Whitney
U-test and snus use which was tested with Fisher’s exact test
aNRT, Zyban®, Champix®
bContempl.: contemplation. Precont.: precontemplation
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were smoke-free [13]. Among responders to the present
drop-out study, 45 % were smoke-free at 29–48 months
after their first call to the SNTQ (Table 2).
A previous drop-out study at the SNTQ found only a
small difference (31 % vs. 28 %) in favour of the
responders [10]. The observed difference between the
results of these two studies in terms of the reported quit
rates at the time of drop-out analysis may be explained
as follows. In the previous study, the initial response rate
at 12-month was higher, i.e., 71 % compared with 59 %
in the present study. In addition, the time between the
12-month follow-up and the drop-out analysis was con-
siderably shorter in the previous study, i.e., 4 months
compared with 29–48 months in the present study.
Otherwise, the data collection methods were similar and
the definition of the study base and the questions used
to assess abstinence were the same in both studies.
As shown in Table 4, a large proportion of non-
smokers at 12 months remained abstinent (approxi-
mately seven out of ten), and one out of three smokers
at 12 months reported that they were non-smokers in
the current long-term follow-up. The stable long-term
abstinence rate from 12-month follow-up until the drop-
out study agreed with our previous long-term (5–8 years)
follow-up of smokers treated at dental clinics, where we
detected a stable and somewhat increasing proportion of
quitters after the initial 12-month follow-up (with 8 %
for 5 years) [15].
Among the initial responders to the 12-month follow-
up, the abstinence rate was considerably higher at the
drop-out assessment compared with that at the 12-month
follow-up in the original RCT study (point prevalence
54 % vs. 47 %, 6-month continuous abstinence 49 % vs.
35 %) (Table 2 and [13]). This may be explained by posi-
tive selection; that the responders in both assessments
were those who were most likely to be abstinent. An
increase in proportion of abstinent smokers over time, as
noted in previous long-term follow-ups [15–17], may also
partly explain the difference.
In ITT-analyses that treated all of the non-
responders in the drop-out analysis as smokers, the
point prevalence abstinence was 33 % (50/150) (initial
responders 45 % vs. initial non-responders 20 %, p = .001)
and the 6-month continuous abstinence was 28 % (42/
149) (initial responders 41 % vs. initial non-responders
13 %, p < .001) (not shown in the tables). Thus, the ITT
abstinence rates were approximately 10 % lower than the
abstinence rates among the responders in the present
study (Table 2). Based on a comparison of 111 clients who
responded to the drop-out study and 39 who did not, we
found that responders were significantly older and more
likely to be smoke-free at 12 months. However, we found
no significant differences in terms of the sex distribution,
baseline use of cigarettes, snus or pharmaceuticals, and ex-
posure to second-hand smoke (not shown in the tables).
ITT analyses in tobacco cessation studies will not over-
estimate effectiveness; but the true or real abstinence
rates are probably between the results of ITT analyses
and per protocol-/responder-only analyses. Therefore, it
may be possible to estimate the true/real abstinence rate
by correcting for the responder-only abstinence. Thus,
we propose the use of a correction factor, which can be
obtained by calculating the relationship between abstin-
ence in the total drop-out sample and among the initial
responders. The point prevalence abstinence was 45 %
in the total drop-out sample and 54 % among initial re-
sponders, so we propose that 45/54 = 0.83 can be used
as a correction factor. The 6-month continuous abstin-
ence was 38 % in the total drop-out sample and 49 %
among initial responders, i.e., 38/49 = 0.78 (Table 2). As-
suming that the relationship between the prevalence of
responders and non-responders is the same at 12 months
Table 3 Logistic regression analysis of abstinence in the drop-out study (OR: odds ratio; CI: confidence interval)
Point prevalence 6-month continuous abstinence
OR (95 % CI) p-value OR (95 % CI) p-value
Proactive vs. reactive (ref) service 0.7 (0.3–1.5) .396 0.7 (0.3–1.5) .351
Responders vs. non-responders (ref) 2.5 (1.1–5.5) .025 3.7 (1.5–8.8) .004
Responders vs. non-responders (ref) after adjusting for service 2.5 (1.1–5.6) .024 3.7 (1.5–8.9) .004
Table 4 Transition of point prevalence abstinence and 6-month continuous abstinence among responders at both the 12-month
follow-up and in drop-out study









Smoke-free at 12-month follow-up 72 (23/32) 28 (9/32) 74 (20/27) 26 (7/27)
Smoker at 12-month follow-up 37 (13/35) 63 (22/35) 33 (13/40) 67 (27/40)
McNemar’s Test p = .523 McNemar’s Test p = .263
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and at long-term (drop-out) follow-up, we propose a
conservative correction factor of 0.8 for self-reported
abstinence in telephone-based cessation studies with a
response rate of approximately 55–65 %.
In the present study, we also aimed to assess whether
the two different support protocols (proactive vs. react-
ive service) yielded different proportions of current
smokers among the non-responders. However, there was
no evidence of that, since the logistic regression analysis
showed that response status was the main variable for
abstinence after adjusting for service type (Table 3).
The decrease in the response rate at the SNTQ over
time is a matter of concern and has appeared although
follow-up procedures have not changed. Even though
the response rate is relatively normal in studies like this
[18–20], there is a possibility of bias due to differential
loss to follow-up because of differences between re-
sponders and non-responders [13]. The responders to
the 12-month follow-up were significantly older, more
likely to be smoke-free at the first call, pharmaceutical
users, and not exposed to second-hand smoke. The re-
sponders also smoked fewer cigarettes/day but they had
been smokers for a longer period of time.
In the present drop-out study, two thirds of the initial
responders answered without a telephone reminder,
whereas almost two thirds of initial non-responders an-
swered after a telephone reminder. The only difference
between those who responded before and after the tele-
phone reminder was that the early responders were
more likely to be smoke-free at 12 months.
A telephone reminder resulted in answers from 69 %
of the responders and 53 % of the non-responders. The
response rate increased from 41 % (62/150) before the
telephone reminder to 74 % (111/150) after the reminder
(Table 1). This increase is comparable to health surveys
with multiple reminders [21–23]. Systematic reviews
have shown that reminder letters and telephone contact,
personalized letters, short questionnaires, and stamped
return envelopes increase the response rate to postal
questionnaires [24–26].
The abstinence rates were higher, but not significantly,
among those who answered without a telephone
reminder than among those who answered after a re-
minder (point prevalence 52 % (32/62) vs. 37 % (18/49),
p = .118 and 6-month continuous abstinence 46 % (28/
61) vs. 29 % (14/49), p = .063) (not shown in the tables).
In our previous long-term follow-up study of smokers
treated at dental clinics, the abstinence rates were also
significantly higher among questionnaire responders
than subsequent telephone responders (p = .001) [15],
but this could also indicate a difference between early
and late responders.
A quite recent study from three American quitlines
(Minnesota, Hawaii, and Florida) reports higher, but not
statistically significant quit rates among earlier than later
responders [20]. The participants were offered incentives
and abstinence measure was 30-day point prevalence
after 7 months (figures between 20 and 40 %), making a
comparison with our quit rates rather meaningless.
A strength of the present study is the relatively high
response rate, but it was not 100 %, so it is also a limita-
tion because of the possible bias due to differential losses
to follow-up. Another strength is that the present study
included a long-term follow-up of the quitline results,
which is very rare to the best of our knowledge. A limi-
tation is that abstinence was self-reported, but self-
reporting is considered to be accurate in most smoking
cessation studies and biochemical verification might not
be desirable in studies where mail, telephone, or the
Internet are the optimal data collection methods [27]. In
addition, the outcome measure was smoking cessation,
so the use of other tobacco products (e.g., snus) and al-
ternative nicotine-delivery methods (e.g., NRT or elec-
tronic “cigarette” vapour) would have complicated any
cotinine measurements performed to validate the self-
reported data. A further limitation is that the response
rate in the drop-out study was higher among the initial
responders (84 %) than that among the initial non-
responders (63 %).
Conclusions
Non-responders to a 12-month follow-up smoking ces-
sation questionnaire in a quitline setting were more
likely to be smokers 1.5–3 years later. We propose a
conservative correction factor of 0.8 for self-reported ab-
stinence in telephone-based cessation studies if the
response rate is approximately 55–65 %.
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